TickerFactsScreenerDevelopers

Oruka Therapeutics, Inc. (ORKA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2003: -$115.0K2004: -$619.0K2005: -$678.0K2006: -$5.74M2007: -$19.69M2008: -$38.18M2009: $7.41M2010: $6.77M2011: $5.73M2012: $2.91M2013: $15.58M2014: $14.74M2015: $38.07M2016: $22.19M2017: $10.28M2018: $6.03M2019: $7.61M2020: $46.52M2021: $51.04M2022: $41.67M2023: $37.02M2024: $382.22M2025: $471.93M$471.93M
2003Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$471.93M+23.5%
2024$382.22M+932.5%
2023$37.02M-11.2%
2022$41.67M-18.4%
2021$51.04M+9.7%
2020$46.52M+511.3%
2019$7.61M+26.2%
2018$6.03M-41.3%
2017$10.28M-53.7%
2016$22.19M-41.7%
2015$38.07M+158.3%
2014$14.74M-5.4%
2013$15.58M+436.0%
2012$2.91M-49.3%
2011$5.73M-15.3%
2010$6.77M-8.6%
2009$7.41M+119.4%
2008-$38.18M-93.9%
2007-$19.69M-242.8%
2006-$5.74M-747.2%
2005-$678.0K-9.5%
2004-$619.0K-438.3%
2003-$115.0K—